Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4220 |  TIL Instil Bio, Inc. - Common Stock | 6.56 USD | -4.23% | -8.76% | -13.00% | -66.34% | 44.49 M USD | ||
| 4223 |  CALC CalciMedica, Inc. - Common Stock | 1.30 USD | -12.16% | -20.73% | -41.44% | -61.54% | 44.38 M USD | ||
| 4227 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | +2.25% | -5.21% | -49.72% | 44.23 M USD | ||
| 4239 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.04 USD | -2.86% | 0.00% | -3.77% | -48.74% | 42.91 M USD | ||
| 4255 |  VERU Veru Inc. - Common Stock | 2.42 USD | -1.63% | -3.59% | -6.56% | +1.26% | 41.26 M USD | ||
| 4258 |  LNAI Lunai Bioworks Inc. - Common Stock | 1.12 USD | +2.75% | -23.29% | -57.58% | -9.68% | 40.62 M USD | ||
| 4285 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 0.99 USD | +1.02% | -9.17% | -15.38% | -31.25% | 37.40 M USD | ||
| 4288 |  LITS Lite Strategy, Inc. - Common Stock | 1.22 USD | -3.94% | -16.44% | +9.91% | -49.38% | 37.10 M USD | ||
| 4309 |  EDSA Edesa Biotech, Inc. - Common Shares | 3.66 USD | -5.91% | -8.73% | -23.75% | +37.08% | 35.29 M USD | ||
| 4321 |  GRDX GridAI Technologies Corp. - Common Stock | 4.80 USD | +16.50% | +34.83% | +59.47% | +88.24% | 34.23 M USD | ||
| 4327 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.92 USD | -2.00% | -8.84% | +9.50% | -69.28% | 34.10 M USD | ||
| 4331 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.08 USD | 0.00% | -6.09% | -14.29% | +3.85% | 33.96 M USD | ||
| 4332 |  CVM Cel-Sci Corporation Common Stock | 1.93 USD | -9.39% | -9.81% | +16.27% | -62.52% | 33.95 M USD | ||
| 4339 |  NNVC NanoViricides, Inc. Common Stock | 1.31 USD | -9.03% | +4.80% | +18.02% | +29.70% | 33.44 M USD | ||
| 4342 |  ALGS Aligos Therapeutics, Inc. - Common stock | 5.31 USD | -0.19% | -7.17% | -8.29% | -45.76% | 33.12 M USD | ||
| 4365 |  NXTC NextCure, Inc. - Common Stock | 6.78 USD | +3.35% | +31.14% | -20.89% | -48.24% | 31.03 M USD | ||
| 4372 |  QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 USD | +9.88% | -2.78% | -2.13% | +1298.10% | 29.86 M USD | ||
| 4382 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.71 USD | -2.84% | +8.23% | -8.06% | -82.02% | 28.95 M USD | ||
| 4383 |  IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | -3.45% | +7.69% | 28.95 M USD | ||
| 4394 |  CNTX Context Therapeutics Inc. - Common Stock | 0.30 USD | -3.23% | -3.23% | -18.92% | -79.59% | 27.56 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |